Prostatic artery embolization (PAE) has recently been described as a promising alternative treatment for lower urinary tract symptoms (LUTS) due to an enlarged, benign prostate.
Purpose
To evaluate the safety, morbidity, and functional outcomes after PAE.
Material and Methods
Twenty-nine consecutive patients were included. All patients had computed tomography angiography before the procedure. Microcatheters were used for selective embolization of the PAs. Large side branches to non-target organs were embolized with coils. The PAs were embolized with calibrated 300–500 µm tris-acryl gelatin microspheres. Complications were recorded before discharge. Clinical visit was performed after three months, magnetic resonance imaging (MRI) after 6–12 months, and any further intervention recorded in the chart. Mean follow-up was 23 months. Clinical success was defined as no longer needing urinary catheter, no long-term complications, and no need of further interventions.
Results
Sixteen patients (55%) had permanent or intermittent catheter before the procedure. Bilateral embolization was performed in 26 patients (90%). Five patients underwent two procedures. Twelve of 16 patients (75%) with permanent or intermittent catheter were able to remove the catheter. Five patients were operated with transurethral resection of the prostate (TURP). Except for one patient, all patients without catheter at baseline improved in the International Prostate Symptom Score (IPSS) and had no further treatment. Twelve patients experienced complications; all were grade 1 according to the Clavien–Dindo classification.
Conclusion
PAE reduced LUTS symptoms in most patients without severe complications. The treatment did not exclude additional surgical treatment when needed.
SivarajanGBorofskyMSShahO, et al.The role of minimally invasive surgical techniques in the management of large-gland benign prostatic hypertrophy. Rev Urol2015;
17:140–149.
2.
OelkeMBachmannADescazeaudA, et al.
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.Eur Urol2013;
64:118–140.
3.
MarraGSturchPOderdaM, et al.
Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men's ejaculatory function: time for a bespoke approach?Int J Urol2016;
23:22–35.
4.
AhyaiSAGillingPKaplanSA, et al.
Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement.Eur Urol2010;
58:384–397.
5.
MandalSSankhwarSNKathpaliaR, et al.
Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index.Int Urol Nephrol2013;
45:347–354.
6.
van ExelNJKoopmanschapMAMcDonnellJ, et al.
Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH study. EurUrol2006;
49:92–102.
7.
CharlsonMSzatrowskiTPPetersonJ, et al.
Validation of a combined 10 comorbidity index.J Clin Epidemiol1994;
47:1245–1251.
8.
CarnevaleFCAntunesAAda Motta Leal FilhoJM, et al.
Prostatic artery embolization as a primary treatment for benign prostatic hyper- plasia: preliminary results in two patients.Cardiovasc Intervent Radiol2010;
33:355–361.
9.
CarnevaleFCda Motta Leal FilhoJMAntunesAA, et al.
Mid term follow-up after prostate embolization in two patients with benign prostatic hyperplasia.Cardiovasc Intervent Radiol2011;
34:1330–1333.
10.
PiscoJMPinheiroLCBilhimT, et al.
Prostatic arterial embolization to treat benign prostatic hyperplasia.J Vasc Interv Radiol2011;
22:11–19.
11.
UflackerAHaskalZJBilhimT, et al.
Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia.J Vasc Interv Radiol2016;
27:1686–1697.
12.
LiQDuanFWangMQ, et al.
Prostatic arterial embolization with small sized particles for the treatment of lower urinary tract symptoms due to large benign prostatic hyperplasia: preliminary results.Chin Med J (Engl). 2015;
128:2072–2077.
13.
WangMQGuoLPZhangGD, et al.Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population. BMC Urol2015;
15:33.
14.
KurbatovDRussoGILepetukhinA, et al.
Prostatic artery embolization for prostate volume greater than 80 cm3: results from a single-center prospective study.Urology2014;
84:400–404.
15.
MoreiraAMde AssisAMCarnevaleFC, et al.
A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH.Cardiovasc Intervent Radiol2017;
40:1490–1500.
16.
CostaNVPereiraJFernandesL, et al.
Prostatic tissue expulsion after prostatic artery embolization.J Vasc Interv Radiol2016;
27:601–603.
17.
CarnevaleFCIscaifeAYoshinagaEM, et al.
Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): Preliminary results of a single center, prospective, urodynamic-controlled analysis.Cardiovasc Intervent Radiol2016;
39:44–52.
18.
AbtDHechelhammerLMüllhauptG, et al.Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ2018;
361:k2338.
19.
RayAFPowellJSpeakmanMJ, et al.
Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).BJU Int2018;
122:270–282.
20.
RussoGIKurbatovDSansaloneS, et al.
Prostatic arterial embolization vs open prostatectomy: a 1-year matched-pair analysis of functional outcomes and morbidities.Urology2015;
86:343–348.
21.
PiscoJ-MPereiraJTintoHR, et al.
How to perform prostatic arterial embolization.Tech Vasc Interventional Rad2012;
15:286–289.
22.
CarnevaleFCSoaresGRde AssisAM, et al.
Anatomical variants in prostate artery embolization: a pictorial essay.Cardiovasc Intervent Radiol2017;
40:1321–1337.
23.
CarnevaleFCMoreiraAMHarwardSH, et al.
Recurrence of lower urinary tract symptoms following prostate artery embolization for benign hyperplasia: single center experience comparing two techniques.Cardiovasc Intervent Radiol2017;
40:366–374.
24.
AbramsP.Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function.BJU Int1999;
84:14–15.
25.
CarnevaleFCAntunesAA.Prostatic artery embolization for enlarged prostates due to benign prostatic hyperplasia. How I do it.Cardiovasc Intervent Radiol. 2013;
36:1452–1463.
26.
AmouyalGThiounnNPellerinO, et al.
Clinical results after prostatic artery embolization using the PErFecTED technique: a single-center study.Cardiovasc Intervent Radiol2016;
39:367–375.
27.
DindoDDemartinesNClavienPA.Classification of surgical complications.Ann Surg2004;
240:205–213.
28.
RampoldiABarbosaFSeccoS, et al.
Prostatic artery embolization as an alternative to indwelling bladder catheterization to manage benign prostatic hyperplasia in poor surgical candidates.Cardiovasc Intervent Radiol2017;
40:530–536.
29.
PiscoJMBilhimTPinheiroLC, et al.
Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients.J Vasc Interv Radiol2016;
27:1115–1122.
30.
CarnevaleFCda Motta-Leal-FilhoJMAntunesAA, et al.
Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.J Vasc Interv Radiol2013;
24:535–542.
31.
de AssisAMMoreiraAMde Paula RodriguesVC, et al.
Pelvic arterial anatomy relevant to prostatic artery embolisation and proposal for angiographic classification.Cardiovasc Intervent Radiol2015;
38:855–861.
32.
GonçalvesOMCarnevaleFCMoreiraAM, et al.
Comparative study using 100-300 versus 300-500 μm microspheres for symptomatic patients due to enlarged-BPH prostates.Cardiovasc Intervent Radiol2016;
39:1372–1378.
33.
SandhuJSNgCVanderbrinkBA, et al.
High-power potassium-titanyl-phosphate photo selective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.Urology2004;
64:1155–1159.
34.
WestenbergAGillingPKennettK, et al.
Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term follow up. J Urol2004;
172:616–619.
35.
KackerRWilliamsSB.Endourologic procedures for benign prostatic hyperplasia: review of indications and outcomes. Urol J2011;
8:171–176.
